UBE2D1 and hepatocellular carcinoma: Furthermore, there was a significant correlation between UBE2D1 expression and the WHO grade of patients with HCC, with a greater prevalence of elevated UBE2D1 expression in cases of higher malignancy, and conversely, a lower incidence in cases of lower malignancy (Fig. 2C).